Antioxidant, anti-inflammatory and anti-fibrotic effects of Boswellia serrate gum resin in CCl4-induced hepatotoxicity

Heba M Eltahir, Michael A Fawzy, Elhussein M Mohamed, Mahmoud A Alrehany, Ahmed M Shehata, Mekky M Abouzied, Heba M Eltahir, Michael A Fawzy, Elhussein M Mohamed, Mahmoud A Alrehany, Ahmed M Shehata, Mekky M Abouzied

Abstract

The present study aims to investigate the potential antioxidant, anti-inflammatory and anti-fibrotic effects of Boswellia serrate (BS) gum resin against carbon tetrachloride (CCl4)-induced liver damage. Four groups consisting of eight rats each were designated: Group I, normal healthy control; group II, CCl4-induced liver fibrosis; group III, CCl4-induced liver fibrosis followed by BS treatment daily for two weeks; and group IV, CCl4-induced liver fibrosis followed by silymarin treatment daily for two weeks. Expression of tumor necrosis factor-α (TNF-α) and nuclear factor κB (NF-κB), interleukin-6 (IL-6), transforming growth factor-β (TGF-β) and cyclooxygenase-2 (COX-2) were assessed, in addition to histopathological and fibrotic changes in liver tissues isolated from the rats. BS significantly ameliorated CCl4-induced increases in serum aspartate (AST) and alanine transaminase (ALT) levels, reduced lactate dehydrogenase (LDH) activities in addition to restoring total bilirubin, triglyceride and albumin levels. BS treatment also alleviated oxidative stress and improved total antioxidant capacity in the liver, and reduced the expression of TNF-α, NF-κB, TGF-β, IL-6 and COX-2. On a histopathological level, BS treatment also exhibited antifibrotic activity. In conclusion, these findings suggest that BS contains potentially hepatoprotective effects against CCl4-induced liver injury via its antioxidant, anti-inflammatory and antifibrotic characteristics.

Keywords: boswellia serrata; cyclooxygenase-2; hepatoprotective; interleukin-6; liver fibrosis; transforming growth factor-β.

Copyright: © Eltahir et al.

Figures

Figure 1.
Figure 1.
Total antioxidant activity (mM/mg protein) as measured in liver homogenates from the four test groups. A significant reduction in total antioxidant activity in hepatic tissues was observed following CCl4 administration compared with healthy control. BS administration significantly improved CCl4-induced inhibition of total antioxidant activity in an effect that was similar to silymarin. Each value represents the mean ± SEM with 8 rats/group. ***P<0.001 vs. Control and ###P<0.001 vs. CCl4. CCl4, carbon tetrachloride; BS, Boswellia serrata gum extract.
Figure 2.
Figure 2.
Catalase activity (units/mg protein) in liver homogenates from the four test groups. Catalase activity in hepatic tissues showed a significant reduction upon CCl4 administration compared with healthy control. BS administration significantly ameliorated CCl4-induced inhibition of catalase activity in an effect that was similar to silymarin. Each value represents the mean ± SEM with 8 rats/group. ***P<0.001 vs. Control and ###P<0.001 vs. CCl4. CCl4, carbon tetrachloride; BS, Boswellia serrata gum extract.
Figure 3.
Figure 3.
Malondialdehyde (nM/mg protein) levels in liver homogenates from the four test groups. Using malondialdehyde levels as marker, lipid peroxidation in hepatic tissues increased significantly following CCl4 treatment compared with healthy control. BS administration significantly alleviated CCl4-induced lipid peroxidation to levels similar to that produced by silymarin. Each value represents the mean ± SEM with 8 rats/group. ***P<0.001 vs. control group and ###P<0.001 vs. CCl4. MDA, malondialdehyde; CCl4, carbon tetrachloride; BS, Boswellia serrata gum extract.
Figure 4.
Figure 4.
Effect of BS treatment on the expression of nuclear NF-κB and TNF-α levels in liver tissues from the four test groups. (A) Western blot analysis of nuclear NF-κB protein expression using β-actin as an internal loading control. (B) Reverse-transcription-semi quantitative PCR analysis of TNF-α mRNA expression using GAPDH as the internal loading control. A significant increase in NF-κB as well as TNF-α levels was observed after CCl4 treatment which was significantly reversed after BS treatment. (C) Quantified densitometry analysis of (A). (D) Quantified densitometry analysis of (B). Each value represents mean ± SEM for 8 rats/group. ***P<0.001 vs. Control and ###P<0.001 vs. CCl4. CCl4, carbon tetrachloride; BS, Boswellia serrata gum extract; TNF-α, tumor necrosis factor-α.
Figure 5.
Figure 5.
Expression of TGF-β and IL-6 in the serum of the four treatment groups. (A) CCl4 treatment resulted in a significant increase in the serum levels of TGF-β and (B) IL-6 compared with healthy controls. Administration of BS or silymarin after CCl4 treatment partially but significantly restored the serum levels of both markers compared with CCl4. TGF-β, transforming growth factor-β; IL-6, interleukin-6; CCl4, carbon tetrachloride; BS, Boswellia serrata gum extract.
Figure 6.
Figure 6.
Immunohistochemical staining of COX-2. (A) Liver tissue sections from control animals showing almost no staining for COX-2. (B) Prominent COX-2 expression can be observed in liver tissue sections from the CCl4-treated group compared with healthy controls. (C) Liver tissue sections from the BS-treated group or (D) the silymarin group exhibited weaker staining for COX-2 compared with the CCl4-treated group. Arrows indicated COX-2 stained cells. Magnification, ×400. COX-2, cyclooxygenase-2; CCl4, carbon tetrachloride; BS, Boswellia serrata gum extract.
Figure 7.
Figure 7.
Histological examination of liver sections from the four treatment groups following H&E staining. (A) Liver tissue sections from healthy control show normal architecture of hepatocytes. (B) CCl4 treatment resulted in damaged cells, shrunken nuclei, portal infiltration with inflammatory cells (arrows), cystic dilatation of bile duct and fibroplasia in the portal triad and centrilobular congestion. (C) BS treatment resulted in restoration of the normal architecture showing Kupffer cells activation and mild vacuolization (arrows) with the absence of congestion. (D) Similar observations as that produced by B.S with limited focal apoptosis (arrows) can be seen in tissues from the silymarin treatment group. Magnification, ×400. (E) Quantified fibrosis and (F) inflammation scores. Values represent the mean ± SEM of histopathological scoring. **P<0.001 vs. Control and #P<0.001 vs. CCl4. CCl4, carbon tetrachloride; BS, Boswellia serrata gum extract.
Figure 8.
Figure 8.
Histological examination of liver sections from the four treatment groups stained with Masson's trichrome. (A) Liver sections from healthy control showed little staining for collagen fibers. (B) Carbon tetrachloride treatment exhibited moderate fibrous septa formation with positive histochemical staining for collagen fibers. (C) Boswellia serrata gum extract treatment resulted in marked reductions in collagen fiber bundles, in a similar way to that observed in (D) tissues following silymarin treatment. Magnification, ×400. Arrows indicate collagen fibers in the different test groups.

References

    1. Jia C. Advances in the regulation of liver regeneration. Expert Rev Gastroenterol Hepatol. 2011;5:105–121. doi: 10.1586/egh.10.87.
    1. Biswas SK. Does the Interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxid Med Cell Longev. 2016;2016:5698931. doi: 10.1155/2016/5698931.
    1. Rates SM. Plants as source of drugs. Toxicon. 2001;39:603–613. doi: 10.1016/S0041-0101(00)00154-9.
    1. Liu J, Wang X, Liu R, Liu Y, Zhang T, Fu H, Hai C. Oleanolic acid co-administration alleviates ethanol-induced hepatic injury via Nrf-2 and ethanol-metabolizing modulating in rats. Chem Biol Interact. 2014;221:88–98. doi: 10.1016/j.cbi.2014.07.017.
    1. Cui Y, Yang X, Lu X, Chen J, Zhao Y. Protective effects of polyphenols-enriched extract from Huangshan Maofeng green tea against CCl4-induced liver injury in mice. Chem Biol Interact. 2014;220:75–83. doi: 10.1016/j.cbi.2014.06.018.
    1. Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee-a randomized double blind placebo controlled trial. Phytomedicine. 2003;10:3–7. doi: 10.1078/094471103321648593.
    1. Ammon HP. Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine. 2010;17:862–867. doi: 10.1016/j.phymed.2010.03.003.
    1. Zhang Y, Ning Z, Lu C, Zhao S, Wang J, Liu B, Xu X, Liu Y. Triterpenoid resinous metabolites from the genus Boswellia: Pharmacological activities and potential species-identifying properties. Chem Cent J. 2013;7:153. doi: 10.1186/1752-153X-7-153.
    1. Cuaz-Pérolin C, Billiet L, Baugé E, Copin C, Scott-Algara D, Genze F, Büchele B, Syrovets T, Simmet T, Rouis M. Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- mice. Arterioscler Thromb Vasc Biol. 2008;28:272–277. doi: 10.1161/ATVBAHA.107.155606.
    1. Buchele B, Zugmaier W, Simmet T. Analysis of pentacyclic triterpenic acids from frankincense gum resins and related phytopharmaceuticals by high-performance liquid chromatography. Identification of lupeolic acid, a novel pentacyclic triterpene. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;791:21–30. doi: 10.1016/S1570-0232(03)00160-0.
    1. Umar S, Umar K, Sarwar AH, Khan A, Ahmad N, Ahmad S, Katiyar CK, Husain SA, Khan HA. Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis. Phytomedicine. 2014;21:847–856. doi: 10.1016/j.phymed.2014.02.001.
    1. Liu JJ, Toy WC, Liu S, Cheng A, Lim BK, Subramaniam T, Sum CF, Lim SC. Acetyl-keto-β-boswellic acid induces lipolysis in mature adipocytes. Biochem Biophys Res Commun. 2013;431:192–196. doi: 10.1016/j.bbrc.2012.12.136.
    1. Altmann A, Poeckel D, Fischer L, Schubert-Zsilavecz M, Steinhilber D, Werz O. Coupling of boswellic acid-induced Ca2+ mobilisation and MAPK activation to lipid metabolism and peroxide formation in human leucocytes. Br J Pharmacol. 2004;141:223–232. doi: 10.1038/sj.bjp.0705604.
    1. Vargas-Mendoza N, Madrigal-Santillán E, Morales-González A, Esquivel-Soto J, Esquivel-Chirino C, García-Luna Y, González-Rubio M, Gayosso-de-Lucio JA, Morales-González JA. Hepatoprotective effect of silymarin. World J Hepatol. 2014;6:144–149. doi: 10.4254/wjh.v6.i3.144.
    1. Wang G, Li Z, Li H, Li J, Yu C. Metabolic profile changes of CCl4-liver fibrosis and inhibitory effects of jiaqi ganxian granule. Molecules. 2016;21:698. doi: 10.3390/molecules21060698.
    1. Shehata AM, Quintanilla-Fend L, Bettio S, Singh CB, Ammon HP. Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE) Phytomedicine. 2011;18:1037–1044. doi: 10.1016/j.phymed.2011.06.035.
    1. Abouzied MM, Eltahir HM, Abdel Aziz MA, Ahmed NS, Abd El-Ghany AA, Abd El-Aziz EA, Abd El-Aziz HO. Curcumin ameliorate DENA-induced HCC via modulating TGF-β, AKT and caspase-3 expression in experimental rat model. Tumour Biol. 2015;36:1763–1771. doi: 10.1007/s13277-014-2778-z.
    1. Zhao J, Zheng H, Liu Y, Lin J, Zhong X, Xu W, Hong Z, Peng J. Anti-inflammatory effects of total alkaloids from Rubus alceifolius Poir [corrected]. on non-alcoholic fatty liver disease through regulation of the NF-κB pathway. Int J Mol Med. 2013;31:931–937. doi: 10.3892/ijmm.2013.1281.
    1. Suvik A, Effendy AWM. The use of modified Masson's trichrome staining in collagen enaluation in wound healing study. Malays J Vet Res. 2012;3:39–47.
    1. Wójcik M, Ramadori P, Blaschke M, Sultan S, Khan S, Malik IA, Naz N, Martius G, Ramadori G, Schultze FC. Immunodetection of cyclooxygenase-2 (COX-2) is restricted to tissue macrophages in normal rat liver and to recruited mononuclear phagocytes in liver injury and cholangiocarcinoma. Histochem Cell Biol. 2012;137:217–233. doi: 10.1007/s00418-011-0889-9.
    1. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: The Knodell histology activity index and beyond. Hepatology. 2000;31:241–246. doi: 10.1002/hep.510310136.
    1. Ammon HP. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006;72:1100–1116. doi: 10.1055/s-2006-947227.
    1. Tawab MA, Kaunzinger A, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Development of a high-performance liquid chromatographic method for the determination of 11-keto-beta-boswellic acid in human plasma. J Chromatogr B Biomed Sci Appl. 2001;761:221–227. doi: 10.1016/S0378-4347(01)00335-8.
    1. Tabor E. Hepatocellular carcinoma: Global epidemiology. Dig Liver Dis. 2001;33:115–117. doi: 10.1016/S1590-8658(01)80062-1.
    1. Rasool M, Iqbal J, Malik A, Ramzan HS, Qureshi MS, Asif M, Qazi MH, Kamal MA, Chaudhary AG, Al-Qahtani MH, et al. Hepatoprotective effects of Silybum marianum (Silymarin) and Glycyrrhiza glabra (Glycyrrhizin) in combination: A possible synergy. Evid Based Complement Alternat Med. 2014;2014:641597. doi: 10.1155/2014/641597.
    1. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci. 2002;65:166–176. doi: 10.1093/toxsci/65.2.166.
    1. Recknagel RO, Glende EA, Jr, Dolak JA, Waller RL. Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther. 1989;43:139–154. doi: 10.1016/0163-7258(89)90050-8.
    1. Dinarello CA. Proinflammatory cytokines. Chest. 2000;118:503–508. doi: 10.1378/chest.118.2.503.
    1. Cohen-Naftaly M, Friedman SL. Current status of novel antifibrotic therapies in patients with chronic liver disease. Therap Adv Gastroenterol. 2011;4:391–417. doi: 10.1177/1756283X11413002.
    1. Meyer DH, Bachem MG, Gressner AM. Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type beta 1 and type alpha. Biochem Biophys Res Commun. 1990;171:1122–1129. doi: 10.1016/0006-291X(90)90801-S.
    1. Gambhir S, Vyas D, Hollis M, Aekka A, Vyas A. Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies. World J Gastroenterol. 2015;21:3174–3183. doi: 10.3748/wjg.v21.i11.3174.
    1. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. 2007;13:1324–1332. doi: 10.1038/nm1663.
    1. Cheng J, Hada T. The significance of COX-2 and COX-2 inhibitors in liver fibrosis and liver cancer. Cur Med Che Anti Infl Anti Allergy Agents. 2005;4:199–206. doi: 10.2174/1568014053507122.
    1. Brattin WJ, Glende EA, Jr, Recknagel RO. Pathological mechanisms in carbon tetrachloride hepatotoxicity. J Free Radic Biol Med. 1985;1:27–38. doi: 10.1016/0748-5514(85)90026-1.
    1. Younis T, Khan MR, Sajid M. Protective effects of Fraxinus xanthoxyloides (Wall.) leaves against CCl4 induced hepatic toxicity in rat. BMC Complement Altern Med. 2016;16:407. doi: 10.1186/s12906-016-1398-0.
    1. Singh P, Chacko KM, Aggarwal ML, Bhat B, Khandal RK, Sultana S, Kuruvilla BT. A-90 day gavage safety assessment of Boswellia serrata in rats. Toxicol Int. 2012;19:273–278. doi: 10.4103/0971-6580.103668.
    1. Takahashi M, Sung B, Shen Y, Hur K, Link A, Boland CR, Aggarwal BB, Goel A. Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family. Carcinogenesis. 2012;33:2441–2449. doi: 10.1093/carcin/bgs286.

Source: PubMed

3
Tilaa